دورية أكاديمية

Management of gestational hypothyroidism: results of a Brazilian survey.

التفاصيل البيبلوغرافية
العنوان: Management of gestational hypothyroidism: results of a Brazilian survey.
المؤلفون: Villagelin D; Pontifícia Universidade Católica de Campinas, Campinas, SP, Brazil., Comarella AP; Universidade Federal do Espírito Santo, Vitória, ES, Brazil., Tiago DB; PUC-Campinas, Campinas, SP, Brasil., Ward LS; Laboratório de Genética Molecular do Câncer, FCM, Unicamp, Campinas, SP, Brasil.
المصدر: Archives of endocrinology and metabolism [Arch Endocrinol Metab] 2016 Feb; Vol. 60 (1), pp. 16-20. Date of Electronic Publication: 2015 Aug 28.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Segmento Farma Editores Country of Publication: Brazil NLM ID: 101652058 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2359-4292 (Electronic) Linking ISSN: 23593997 NLM ISO Abbreviation: Arch Endocrinol Metab Subsets: MEDLINE
أسماء مطبوعة: Original Publication: São Paulo, SP : Segmento Farma Editores
مواضيع طبية MeSH: Disease Management* , Preconception Care*, Hypothyroidism/*diagnosis , Hypothyroidism/*therapy , Pregnancy Complications/*diagnosis , Thyroxine/*blood, Brazil ; Clinical Decision-Making ; Endocrinology/statistics & numerical data ; Female ; General Practice/statistics & numerical data ; Gynecology/statistics & numerical data ; Humans ; Hypothyroidism/blood ; Obstetrics/statistics & numerical data ; Practice Guidelines as Topic ; Pregnancy ; Pregnancy Complications/blood ; Surveys and Questionnaires ; Thyroxine/therapeutic use
مستخلص: Objectives: Evaluate the management of hypothyroidism in fertile-aged and pregnant women and compare these practices to the recommendations of the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Latin American Thyroid Society, published in 2013.
Materials and Methods: In the first trimester of 2014, SBEM made available to all members an electronic questionnaire based on clinical scenarios in the management of gestational hypothyroidism. The responses of 406 physicians, most of them endocrinologists, were analyzed.
Results: Eighty-one per cent of the endocrinologists screen all their pregnant patients for thyroid dysfunction, mostly during the pregestational period or after the first prenatal visit. Following screening, 82% of the respondents initiate treatment when TSH levels are > 2.5 mIU/L while 67% monitor their pregnant patients even if TSH was normal on first trimester screening. For hypothyroid women who are planning pregnancy, 96% of the clinicians are aware of the importance of adjusting the levothyroxine (LT4) dose as soon as pregnancy is confirmed. However, opinions diverge with respect to adjusting the LT4 dose before or after reassessing thyroid function. The most widely used tests for monitoring pregnant women in use of LT4 are TSH and free T4 (62%) or TSH alone (21%). Unanimously, the treatment goal is to achieve the target TSH level for each trimester of gestation.
Conclusion: The recommendations of the consensus statements are incorporated into the respondents' clinical practice. It is noteworthy that the great majority of the clinicians favor universal screening.
References: Arq Bras Endocrinol Metabol. 2013 Apr;57(3):166-83. (PMID: 23681263)
Ann Clin Lab Sci. 1991 Jul-Aug;21(4):227-39. (PMID: 1859163)
Thyroid. 1999 Jan;9(1):19-24. (PMID: 10037071)
J Clin Endocrinol Metab. 2012 Aug;97(8):2543-65. (PMID: 22869843)
Eur J Endocrinol. 2010 Apr;162(4):643-52. (PMID: 19955261)
Obstet Gynecol. 2005 Feb;105(2):239-45. (PMID: 15684146)
Eur J Endocrinol. 2013 Nov 29;170(1):R17-30. (PMID: 24128429)
Obstet Gynecol. 1993 Mar;81(3):349-53. (PMID: 8437784)
Thyroid. 2011 Oct;21(10):1081-125. (PMID: 21787128)
J Endocrinol Invest. 2011 Feb;34(2):155-8. (PMID: 21422804)
Arq Bras Endocrinol Metabol. 2013 Jun;57(4):265-91. (PMID: 23828433)
N Engl J Med. 1999 Aug 19;341(8):549-55. (PMID: 10451459)
Endocr Pract. 2012 Nov-Dec;18(6):988-1028. (PMID: 23246686)
Med Clin (Barc). 2009 Apr 25;132(15):569-73. (PMID: 19375116)
J Clin Endocrinol Metab. 2012 May;97(5):1536-46. (PMID: 22399510)
Thyroid. 2002 Jan;12(1):63-8. (PMID: 11838732)
Eur J Endocrinol. 2012 Jan;166(1):49-54. (PMID: 22023792)
J Clin Endocrinol Metab. 1991 Aug;73(2):421-7. (PMID: 1906897)
Eur J Endocrinol. 2004 Jun;150(6):751-5. (PMID: 15191343)
المشرفين على المادة: Q51BO43MG4 (Thyroxine)
تواريخ الأحداث: Date Created: 20150903 Date Completed: 20160927 Latest Revision: 20230422
رمز التحديث: 20230422
مُعرف محوري في PubMed: PMC10118917
DOI: 10.1590/2359-3997000000069
PMID: 26331227
قاعدة البيانات: MEDLINE
الوصف
تدمد:2359-4292
DOI:10.1590/2359-3997000000069